Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Sale | 2024-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | FMR LLC | 2,423,213 9.400% | -299,443 (-11.00%) | Filing History |
| 2025-01-15 4:25 pm Purchase | 2025-01-13 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 9,555,394 36.900% | 21,178 (+0.22%) | Filing History |
| 2024-12-23 8:22 pm Purchase | 2024-12-19 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 9,534,216 36.800% | 52,400 (+0.55%) | Filing History |
| 2024-11-18 9:44 pm Purchase | 2024-11-14 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 9,481,816 37.100% | 434,128 (+4.80%) | Filing History |
| 2024-10-15 4:30 pm Purchase | 2024-10-11 | 13D | Cartesian Therapeutics, Inc. RNAC | Kalayoglu Murat | 5,058,026 19.900% | 1,519,640 (+42.95%) | Filing History |
| 2024-10-04 6:08 pm Purchase | 2024-10-02 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 9,047,688 37.600% | 205,932 (+2.33%) | Filing History |
| 2024-09-27 4:20 pm Purchase | 2024-09-25 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 8,841,756 36.700% | 8,650 (+0.10%) | Filing History |
| 2024-08-12 09:40 am Purchase | 2024-08-09 | 13G | Cartesian Therapeutics, Inc. RNAC | FMR LLC | 2,722,656 12.734% | 2,024,768 (+290.13%) | Filing History |
| 2024-07-12 6:12 pm Purchase | 2024-07-12 | 13G | Cartesian Therapeutics, Inc. RNAC | Artal Participations S.a r.l | 594,940 2.800% | 246,412 (+70.70%) | Filing History |
| 2024-07-05 4:15 pm Purchase | 2024-07-02 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 8,833,106 36.300% | 8,833,106 (New Position) | Filing History |
| 2024-05-10 10:03 am Purchase | 2024-05-09 | 13G | Cartesian Therapeutics, Inc. RNAC | FMR LLC | 697,888 3.925% | 697,888 (New Position) | Filing History |
| 2024-04-12 4:24 pm Purchase | 2024-04-08 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 6,473,184 36.400% | 207 (+0.00%) | Filing History |
| 2024-04-10 4:29 pm Purchase | 2024-04-08 | 13D | Cartesian Therapeutics, Inc. RNAC | Kalayoglu Murat | 3,538,386 19.900% | 2,226,904 (+169.80%) | Filing History |
| 2024-04-10 4:25 pm Sale | 2024-04-08 | 13D | Cartesian Therapeutics, Inc. RNAC | Singer Michael | 769,744 4.300% | -98,954 (-11.39%) | Filing History |
| 2024-03-28 5:27 pm Purchase | 2024-03-26 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 6,472,977 27.900% | 41,622 (+0.65%) | Filing History |
| 2024-03-11 08:19 am Purchase | 2024-03-08 | 13G | Cartesian Therapeutics, Inc. RNAC | FMR LLC | 562,307 10.417% | 120,428 (+27.25%) | Filing History |
| 2024-02-14 12:38 pm Sale | 2023-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | MANGROVE PARTNERS IM LLC | 137,575 2.590% | -175,347 (-56.04%) | Filing History |
| 2024-02-09 5:13 pm Purchase | 2023-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC | Artal Participations S.a r.l | 348,528 6.400% | 8,295 (+2.44%) | Filing History |
| 2024-02-09 08:50 am Purchase | 2024-02-08 | 13G | Cartesian Therapeutics, Inc. RNAC | FMR LLC | 441,879 8.186% | 441,879 (New Position) | Filing History |
| 2023-11-22 4:39 pm Purchase | 2023-11-13 | 13D | Cartesian Therapeutics, Inc. RNAC | Singer Michael | 868,698 13.900% | 868,698 (New Position) | Filing History |